Gao Y, Liu M, Yang K, et al. Shorter Versus Longer-term Antibiotic Treatments for Community-Acquired Pneumonia In Children: A Meta-Analysis. Pediatrics. 2023;151(6):E2022060097
Pratt MTG, Tasnim PC, Richmond HC, et al. Prevalence of respiratory viruses in community- acquired pneumonia in children: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2022;6:555-70.
Kuitunen JJ, Korppi M, Renko M. Antibiotic treatment duration for community acquired pneumonia in outpatient children in high-income countries – a systematic review and meta- analysis. Clin Infect Dis. 2022 May 17:ciac374.
Chee E, Huang K, Haggie S, et al. Systematic review of clinical practice guidelines on the management of community acquired pneumonia in children. Paediatr Respir Rev. 2022;42:59- 68.
Weragama K, Mudgil P, Whitehall J. Paediatric antimicrobial stewardship for respiratory infections in the emergency setting: A systematic review. Antibiotics (Basel). 2021;10(11).
Lassi ZS, Padhani ZA, Das JK, et al. Antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with WHO-defined non-severe pneumonia and wheeze. Cochrane Database Syst Rev. 2021;1(1):Cd009576.
Wang L, Song W, Wang Y, et al. Lung ultrasonography versus chest radiography for the diagnosis of pediatric community acquired pneumonia in emergency department: a meta- analysis. J Thorac Dis. 2019;11(12):5107-14.
Shah SN, Bachur RG, Simel DL, et al. Does this child have pneumonia? The rational clinical examination systematic review. JAMA. 2017;318(5):462-71.
Wang K, Gill P, Perera R, Thomson A, Mant D, Harnden A. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community‐acquired pneumonia. Cochrane Database Syst Rev. 2012(10).